W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

24 March, 2026
Communication of the meeting of Transparency Council No. 11/2026 on 16 March 2026 with resolutions
read more
24 March, 2026
Recommendation of the President – MSUD Anamix Infant, MSUD Anamix Junior, MSUD Anamix Junior LQ, MSUD Gel, MSUD Cooler, MSUD Express, and MSUD Lophlex LQ
read more
24 March, 2026
Recommendation of the President – Hympavzi (marstacimab)
read more
20 March, 2026
Publication AWA
read more
20 March, 2026
Status of work
read more
20 March, 2026
The Transparency Council meeting 13/2026 on 30 March 2026
read more
20 March, 2026
List of Highly Innovative Pharmaceutical Technologies (TLI)
read more
18 March, 2026
Recommendation of the President – Bupropion Neuraxpharm (bupropion hydrochloride)
read more
18 March, 2026
Recommendation of the President – Kinpeygo (budesonide)
read more
17 March, 2026
Recommendation of the President – Darzalex (daratumumab)
read more
13 March, 2026
Publication AWA
read more
13 March, 2026
Status of work
read more
13 March, 2026
Communication of the meeting of Transparency Council No. 10/2026 on 9 March with resolutions
read more
13 March, 2026
The Transparency Council meeting 12/2026 on 23 March 2026
read more
12 March, 2026
Opinion of the President – Preventive Care for Cataract and Glaucoma Diagnosis and AMD (Age-Related Macular Degeneration) for Residents of the Konstancin-Jeziorna Municipality for the year 2026
read more
10 March, 2026
Recommendation of the President – Blenrep (belantamab mafodotin)
read more
10 March, 2026
Announcement regarding the meeting of the Tariff Council on 26 February 2026
read more
09 March, 2026
Communication of the meeting of Transparency Council No. 8/2026 on 23 February 2026 with resolutions
read more
06 March, 2026
Publication AWA
read more
06 March, 2026
Status of work in March
read more
06 March, 2026
The Transparency Council meeting 11/2026 on 16 March 2026
read more
06 March, 2026
Communication of the meeting of Transparency Council No. 9/2026 on 2 March 2026 with resolutions
read more
05 March, 2026
Recommendation of the President – Beyonttra (akoramidis)
read more
02 March, 2026
Recommendation of the President – Agamree (vamorol)
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑